C. Mayato et al. / Tetrahedron: Asymmetry 15 (2004) 2385–2397
2393
4.13. Cyclohexyl 3,4,6-tri-O-benzyl-b-D-mannopyrano-
side 9
1H), 4.69 (d, J=11.8Hz, 1H), 4.63 (d, J=12.2Hz, 1H),
4.59 (d, J=12.2Hz, 1H), 4.58 (d, J=10.9Hz, 1H),
4.46 (s, H-1), 4.10 (d, J=2.3Hz, H-2), 3.86–3.78 (m,
2H), 3.70 (dd, J=5.8 and 10.7Hz, H-6proR), 3.57 (dd,
J=2.4 and 9.0Hz, H-3), 3.48–3.40 (m, 2H), 2.28 (m,
1H), 2.10 (m, 1H), 1.64(m, 2H), 1.40–1.28 (m, 2H),
1.40 (q, J=11.7Hz, 1H), 1.00–0.83 (m, 8H), 0.76 (d,
J=6.9Hz, 3H); 13C NMR (CDCl3) d 138.2 (s), 138.1
(s), 137.7 (s), 128.1–127.2 (aromatic Cs), 100.9 (d,
C-1), 81.7 (d, C-3), 81.3 (d, C-10), 75.0 (d, C-5), 74.8
(t), 74.1 (d, C-4), 73.2 (t), 71.0 (t), 69.3 (t, C-6), 68.3
(d, C-2), 48.0 (d), 43.0 (t), 34.0 (t), 31.4 (d), 25.4 (d),
22.9 (t), 22.0 (q), 20.9 (q), 16.0 (q); Anal. Calcd
for C37H48O6: C, 75.48; H, 8.22. Found: C, 75.45; H,
8.34.
Synthesis of compound 9 was carried out from 3
(437mg, 0.82mmol) as described in the general proce-
dure for b-mannosides. Column chromatography (n-
hexane/EtOAc, 7.5:2.5) of the residue gave 9 (267mg,
0.50mmol, 61%): TLC Rf =0.21 (n-hexane/EtOAc,
7.5:2.5); [a]D =ꢀ27.7 (c 2.6, CHCl3); MS (EI) m/z (rela-
tive intensity) 441 ([M+ꢀC7H7], 0.6), 341 (4.7), 91 (100);
1H NMR (CDCl3) d 7.38–7.24(m, 15H), .490 (d,
J=10.9Hz, 1H), 4.79 (d, J=11.9Hz, 1H), 4.67 (d,
J=11.9Hz, 1H), 4.62 (d, J=12.1Hz, 1H), 4.58–4.53
(m, 2H), 4.54 (s, H-1), 4.07 (d, J=2.6Hz, H-2), 3.84(t,
J=9.4Hz, H-04), 3.79 (dd, J=1.9 and 10.8Hz, H-6proS),
3.74(m, H-1 ), 3.69 (dd, J=5.7 and 10.8Hz, H-6proR),
3.57 (dd, J=3.1 and 9.1Hz, H-3), 3.43 (m, H-5), 2.00
(m, 1H), 1.88 (m, 1H), 1.74(m, 2H), 1.54(m, 1H),
1.45 (m, 1H), 1.33–1.18 (m, 4H); 13C NMR (CDCl3) d
138.2 (s), 138.1 (s), 137.7 (s), 128.2–127.3 0 (aromatic
Cs), 97.2 (d, C-1), 81.5 (d, C-3), 76.4(d, C-1 ), 75.0 (d,
C-5), 74.9 (t), 74.1 (d, C-4), 73.2 (t), 71.0 (t), 69.2 (t,
C-6), 68.6 (d, C-2), 33.3 (t), 31.5 (t), 25.4(t), 23.9 (t),
23.8 (t); Anal. Calcd for C33H40O6: C, 74.41; H, 7.57.
Found: C, 74.42; H, 7.56.
4.16. tert-Butyl 3,4,6-tri-O-benzyl-b-D-mannopyranoside
12
Compound 12 was synthesized from
6 (376mg,
0.74mmol) as described in the general procedure for
preparation of b-mannosides. Column chromatography
(n-hexane/EtOAc, 8.5:1.5) of the residue gave com-
pound 12 (218mg, 0.43mmol, 58%): TLC Rf =0.19 (n-
hexane/EtOAc, 7.5:2.5); [a]D =ꢀ28.5 (c 1.9, CHCl3);
MS (EI) m/z (relative intensity) 415 ([M+ꢀC7H7], 0.2),
1
4.14. (1R,2S,5R)-Menthyl 3,4,6-tri-O-benzyl-b-D-
mannopyranoside 10
341 (3.1), 91 (100); H NMR (CDCl3) d 7.40–7.22 (m,
15H), 4.91 (d, J=10.9Hz, 1H), 4.79 (d, J=11.9Hz,
1H), 4.69 (d, J=11.9Hz, 1H), 4.61 (d, J=12.1Hz, 1H),
4.60 (s, H-1), 4.56 (d, J=10.9Hz, 1H), 4.55 (d,
J=12.1Hz, 1H), 3.99 (d, J=3.1Hz, H-2), 3.83 (t,
J=9.4Hz, H-4), 3.76 (dd, J=1.7 and 10.7Hz, H-6proS),
3.68 (dd, J=5.7 and 10.7Hz, H-6proR), 3.59 (dd, J=3.1
and 9.1Hz, H-3), 3.42 (m, H-5), 1.30 (s, 9H); 13C
NMR (CDCl3) d 138.2 (s), 138.1 (s), 137.7 (s), 128.1–
127.1 (aromatic Cs), 94.1 (d, C-1), 81.7 (d, C-3), 75.9
(s, C-20), 74.7 (t), 74.6 (d, C-5), 74.0 (d, C-4), 73.0 (t),
70.9 (t), 69.3 (d, C-2), 69.2 (t, C-6), 28.4(q ·3); Anal.
Calcd for C31H38O6: C, 73.49; H, 7.56. Found: C,
73.46; H, 7.82.
Following the procedure for b-mannosides, compound
10 was obtained from glucopyranoside 4 (611mg,
1.04mmol) with a 65% yield (395mg, 0.67mmol), after
column chromatography (n-hexane/EtOAc, 9:1): TLC
Rf =0.44 (n-hexane/EtOAc, 7.5:2.5); [a]D =ꢀ49.6 (c 1.6,
CHCl3); MS (EI) m/z (relative intensity) 497
([M+ꢀC7H7], 0.3), 341 (2.5), 91 (100); 1H NMR (CDCl3)
d 7.39–7.24 (m, 15H), 4.90 (d, J=10.9Hz, 1H), 4.79 (d,
J=12.0Hz, 1H), 4.67 (d, J=12.0Hz, 1H), 4.63–4.56
(m, 3H), 4.53 (s, H-1), 4.02 (d, J=2.9Hz, H-2), 3.86
(t, J=9.5Hz, H-4), 3.74 (dd, J=1.8 and 10.7Hz, H-
6proS), 3.70 (dd, J=5.1 and 10.7Hz, H-6proR), 3.60–
3.54 (m, 2H), 3.40 (m, H-5), 2.28 (m, 1H), 1.98 (d,
J=12.1Hz, 1H), 1.65 (d, J=12.2Hz, 2H), 1.35 (m,
1H), 1.28 (m, 1H), 1.00–0.81 (m, 12H); 13C NMR
(CDCl3) d 138.4 (s), 138.3 (s), 138.0 (s), 128.4–127.5
(aromatic Cs), 96.1 (d, C-1), 81.9 (d, C-3), 76.5 (d, C-
10), 75.3 (d, C-5), 75.2 (t), 74.4 (d, C-4), 73.6 (t), 71.2
(t), 69.7 (t, C-6), 69.2 (d, C-2), 47.7 (d), 40.4 (t), 34.3
(t), 31.3 (d), 25.3 (d), 23.1 (t), 22.3 (q), 21.0 (q), 15.9
(q); Anal. Calcd for C37H48O6: C, 75.48; H, 8.22.
Found: C, 75.43; H, 8.60.
4.17. Methyl 2,3,4,6-tetra-O-acetyl-b-D-mannopyranoside
13
Following the procedure for debenzylation and acetyl-
ation, using 72mg (0.16mmol) of compound 7, com-
pound 13 (36mg, 0.10mmol) was obtained with a
64% yield after chromatography on silica gel (n-hexane/
EtOAc, 5:5): TLC Rf =0.27 (n-hexane/EtOAc, 1:1);
[a]D =ꢀ43.4 (c 1.1, CHCl3); MS (EI) m/z (relative
intensity) 331 ([M+ꢀCH3O], 2.7), 289 (12.8), 243
1
(32.2), 200 (46.5), 157 (100); H NMR (CDCl3) d 5.48
4.15. (1S,2R,5S)-Menthyl 3,4,6-tri-O-benzyl-b-D-
mannopyranoside 11
(dd, J=0.9 and 3.3Hz, H-2), 5.27 (t, J=10.0Hz, H-4),
5.06 (dd, J=3.3 and 10.0Hz, H-3), 4.56 (d, J=0.9Hz,
H-1), 4.31 (dd, J=5.3 and 12.2Hz, H-6proR), 4.17 (dd,
J=2.6 and 12.2Hz, H-6proS), 3.67 (m, H-5), 3.53 (s, 3
H), 2.19 (s, 3H), 2.10 (s, 3H), 2.05 (s, 3H), 1.99 (s,
3H); 13C NMR (CDCl3) d 170.7 (s), 170.4(s), 170.0
(s), 169.6 (s), 99.7 (d, C-1), 72.4(d, C-5), 71.1 (d, C-3),
68.6 (d, C-2), 66.0 (d, C-4), 62.5 (t, C-6), 57.5 (q,
C-10), 20.8 (q), 20.7 (q), 20.6 (q), 20.5 (q); Anal. Calcd
for C15H22O10: C, 49.72; H, 6.12. Found: C, 49.72; H,
6.41.
Following the procedure for b-mannosides, 324mg
(0.55mmol) of glucopyranoside 5 led to compound 11
(239mg, 0.41mmol, 74%), after column chromatogra-
phy (n-hexane/EtOAc, 9:1): TLC Rf =0.42 (n-hexane/Et-
OAc, 7.5:2.5); [a]D =+8.9 (c 1.1, CHCl3); MS (EI) m/z
(relative intensity) 497 ([M+ꢀC7H7], 0.1), 432 (0.3),
1
341 (3.8), 91 (100); H NMR (CDCl3) d 7.41–7.24 (m,
15H), 4.91 (d, J=10.9Hz, 1H), 4.80 (d, J=11.8Hz,